Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 1
1985 1
1986 1
1989 1
1990 1
1991 5
1992 2
1993 3
1994 1
1995 3
1996 1
1997 1
1998 11
1999 1
2000 8
2001 9
2002 12
2003 15
2004 19
2005 15
2006 16
2007 24
2008 37
2009 41
2010 26
2011 28
2012 43
2013 38
2014 63
2015 62
2016 70
2017 93
2018 92
2019 107
2020 146
2021 166
2022 156
2023 150
2024 82

Text availability

Article attribute

Article type

Publication date

Search Results

1,327 results

Results by year

Filters applied: . Clear all
Page 1
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.
Tanaka M, Fernández-Del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL. Tanaka M, et al. Pancreatology. 2017 Sep-Oct;17(5):738-753. doi: 10.1016/j.pan.2017.07.007. Epub 2017 Jul 13. Pancreatology. 2017. PMID: 28735806 Review.
The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of branch duct IPMN have changed from early resection to more deliberate observation as proposed by the international consensus guidelines of …
The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In particular, the indications for resection of …
International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, Miyasaka Y, Ohno E, Salvia R, Wolfgang CL, Wood LD. Ohtsuka T, et al. Pancreatology. 2024 Mar;24(2):255-270. doi: 10.1016/j.pan.2023.12.009. Epub 2023 Dec 28. Pancreatology. 2024. PMID: 38182527 Free article. Review.
This study group aimed to revise the 2017 international consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and mainly focused on five topics; the revision of high-risk stigmata (HRS) and worrisome features (WF), surve …
This study group aimed to revise the 2017 international consensus guidelines for the management of intraductal papillary mucinous neoplas …
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. McGuigan A, et al. World J Gastroenterol. 2018 Nov 21;24(43):4846-4861. doi: 10.3748/wjg.v24.i43.4846. World J Gastroenterol. 2018. PMID: 30487695 Free PMC article. Review.
The identification of high-risk patients who could benefit from screening to detect pre-malignant conditions such as pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasms and mucinous cystic neoplasms is urgently required, however an …
The identification of high-risk patients who could benefit from screening to detect pre-malignant conditions such as pancreatic intra …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Ilyas SI, Gores GJ. Ilyas SI, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar CCA (pCCA), or distal CCA. ...
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomica …
Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE.
Foley KG, Lahaye MJ, Thoeni RF, Soltes M, Dewhurst C, Barbu ST, Vashist YK, Rafaelsen SR, Arvanitakis M, Perinel J, Wiles R, Roberts SA. Foley KG, et al. Eur Radiol. 2022 May;32(5):3358-3368. doi: 10.1007/s00330-021-08384-w. Epub 2021 Dec 17. Eur Radiol. 2022. PMID: 34918177 Free PMC article.
If the patient has a 6-9 mm polypoid lesion of the gallbladder and one or more risk factors for malignancy, cholecystectomy is recommended if the patient is fit for, and accepts, surgery. ...Strong recommendation, low-moderate quality evidence. 5. If the patient has either …
If the patient has a 6-9 mm polypoid lesion of the gallbladder and one or more risk factors for malignancy, cholecystectomy is recomm …
Extracellular matrix and its therapeutic potential for cancer treatment.
Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, Qiao Y. Huang J, et al. Signal Transduct Target Ther. 2021 Apr 23;6(1):153. doi: 10.1038/s41392-021-00544-0. Signal Transduct Target Ther. 2021. PMID: 33888679 Free PMC article. Review.
During tumorigenesis, the interplay between cancer cells and the tumor microenvironment (TME) often results in the stiffness of the ECM, leading to aberrant mechanotransduction and further malignant transformation. Therefore, a comprehensive understanding of ECM dysregulat …
During tumorigenesis, the interplay between cancer cells and the tumor microenvironment (TME) often results in the stiffness of the ECM, lea …
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Ma ZY, et al. World J Gastroenterol. 2020 May 21;26(19):2305-2322. doi: 10.3748/wjg.v26.i19.2305. World J Gastroenterol. 2020. PMID: 32476795 Free PMC article. Review.
As for drug therapy, steroids and somatostatin analogues are the first-line therapy for those with positive expression of somatostatin receptor, while everolimus and sunitinib represent important progress for the treatment of patients with advanced pNETs. Great prog …
As for drug therapy, steroids and somatostatin analogues are the first-line therapy for those with positive expression of soma …
Advances in the management of pancreatic cancer.
Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Del Chiaro M, et al. BMJ. 2023 Dec 13;383:e073995. doi: 10.1136/bmj-2022-073995. BMJ. 2023. PMID: 38164628 Review.
Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than other cancers. ...
Pancreatic cancer remains among the malignancies with the worst outcomes. Survival has been improving, but at a slower rate than othe …
Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer.
Cao J, Xu H, Li W, Guo Z, Lin Y, Shi Y, Hu W, Ba Y, Li S, Li Z, Wang K, Wu J, He Y, Yang J, Xie C, Zhou F, Song X, Chen G, Ma W, Luo S, Chen Z, Cong M, Ma H, Zhou C, Wang W, Qi Luo, Shi Y, Qi Y, Jiang H, Guan W, Chen J, Chen J, Fang Y, Zhou L, Feng Y, Tan R, Ou J, Zhao Q, Wu J, Xin Lin, Yang L, Fu Z, Wang C, Deng L, Li T, Song C, Shi H; Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group, Chinese Society of Nutritional Oncology. Cao J, et al. Curr Probl Cancer. 2021 Feb;45(1):100638. doi: 10.1016/j.currproblcancer.2020.100638. Epub 2020 Aug 14. Curr Probl Cancer. 2021. PMID: 32829957 Review.
1,327 results